Cell lines expressing an acetylcholine release mechanism; correction of a release-deficient cell by mediatophore transfection. 1996

J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
Départment de Pharmacologie, C.M.U., Genève, Switzerland.

Several neuronal and non-neuronal cell lines express a Ca(2+)-dependent mechanism of transmitter release that can be demonstrated after loading the cells with acetylcholine during culture. In contrast, a particular cell line, the neuroblastoma N18TG-2, was found to be deficient for release. We transfected N18TG-2 cells with a plasmid encoding Torpedo mediatophore, a protein able to translocate acetylcholine in response to calcium. The N18TG-2 cells expressed the Torpedo protein which reached their plasma membrane. At the same time, these cells acquired a Ca(2+)-dependent quantal release mechanism similar to the one naturally expressed by other cell lines. Hence, the presence of mediatophore in the plasma membrane seems essential for quantal release.

UI MeSH Term Description Entries
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014101 Torpedo A genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays. Electric Rays,Torpedinidae,Rays, Electric

Related Publications

J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
May 1999, The European journal of neuroscience,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
September 1999, Canadian journal of physiology and pharmacology,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
March 2000, Metabolic brain disease,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
March 2012, Journal of neuroimmunology,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
February 1994, Journal of neurochemistry,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
January 1993, Journal of physiology, Paris,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
May 1980, Indian journal of experimental biology,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
January 1990, Progress in brain research,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
January 1992, Biology of the cell,
J Falk-Vairant, and F M Meunier, and B Lesbats, and P Corrèges, and L Eder-Colli, and N Salem, and M Synguelakis, and Y Dunant, and M Israël
January 1999, Neuroscience,
Copied contents to your clipboard!